Search hospitals > Illinois > Chicago
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Claim this profileChicago, Illinois 60611
Global Leader in Breast Cancer
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Lung Cancer
Conducts research for Cancer
374 reported clinical trials
11 medical researchers
Summary
Robert H. Lurie Comprehensive Cancer Center at Northwestern University is a medical facility located in Chicago, Illinois. This center is recognized for care of Breast Cancer, Lymphoma, Leukemia, Lung Cancer, Cancer and other specialties. Robert H. Lurie Comprehensive Cancer Center at Northwestern University is involved with conducting 374 clinical trials across 288 conditions. There are 11 research doctors associated with this hospital, such as Mark Agulnik, Sunandana Chandra, Seth M. Pollack, and Devalingam Mahalingam, MBBChBAO.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Mark AgulnikCity of Hope3 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Cancer
23 reported clinical trials
34 drugs studied
Sunandana ChandraNorthwestern University3 years of reported clinical research
Expert in Melanoma
Expert in Skin Cancer
22 reported clinical trials
31 drugs studied
Seth M. PollackNorthwestern University2 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
19 reported clinical trials
29 drugs studied
Devalingam Mahalingam, MBBChBAONorthwestern University6 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
18 reported clinical trials
54 drugs studied
Clinical Trials running at Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Breast Cancer
Cancer
Acute Myeloid Leukemia
Ovarian Cancer
Leukemia
Lymphoma
Acute Myelogenous Leukemia
Endometrial Cancer
Colorectal Cancer
Lung Cancer
RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant
for Breast Cancer
This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.
Recruiting2 awards Phase 35 criteria
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
Utidelone + Capecitabine
for Breast Cancer with Brain Metastases
This study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receive treatment of utidelone alone or in combination with capecitabine. The objectives both in stage I and stage II are to evaluate the intracranial and systemic efficacy and safety of utdelone plus capecitabine for the treatment of HER2-negative breast cancer patients with brain metastases.
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Robert H. Lurie Comprehensive Cancer Center at Northwestern University?
Robert H. Lurie Comprehensive Cancer Center at Northwestern University is a medical facility located in Chicago, Illinois. This center is recognized for care of Breast Cancer, Lymphoma, Leukemia, Lung Cancer, Cancer and other specialties. Robert H. Lurie Comprehensive Cancer Center at Northwestern University is involved with conducting 374 clinical trials across 288 conditions. There are 11 research doctors associated with this hospital, such as Mark Agulnik, Sunandana Chandra, Seth M. Pollack, and Devalingam Mahalingam, MBBChBAO.
Where is Robert H. Lurie Comprehensive Cancer Center at Northwestern University located?
The Robert H. Lurie Comprehensive Cancer Center at Northwestern University is situated in downtown Chicago, IL, on the Northwestern Memorial Hospital campus. It features several locations: the Galter Pavilion at 201 East Huron Street, the Lavin Family Pavilion at 259 E. Erie St, and the Maggie Daley Center for Women's Cancer Care at 250 E. Superior Street. Discounted parking for patients and visitors is available at the Northwestern Memorial Hospital garage, 222 East Huron Street, and at 321 East Erie Street.
Who should I call to ask about financial aid or insurance network?
**Robert H. Lurie Comprehensive Cancer Center - Financial Assistance and Insurance Contact Information**
**Financial Counseling:**
- For outpatient billing concerns and financial assistance programs, contact a financial counselor at 312-926-6906.
**Billing and Financial Assistance:**
- General billing inquiries: Contact the Admitting Department at 877.924.8200. Available Monday - Thursday, 8 a.m. - 6 p.m.; Friday, 8 a.m. - 5 p.m.
- For financial assistance details, including applications and policies, visit the hospital's website.
- Cost estimates: Use the online cost estimation tool or call 312.227.1333 for assistance.
What insurance does Robert H. Lurie Comprehensive Cancer Center at Northwestern University accept?
The Robert H. Lurie Comprehensive Cancer Center at Northwestern University accepts a variety of insurance plans, including Commercial Plans, Medicaid Plans, and Exchange Plans. For Exchange Plans, specifically, the center accepts the Aetna CVS Health PPO and Individual & Family Plans Chicago Land IL PPO for 2024. It's important to verify your coverage by reviewing your plan's benefit book or contacting your plan's customer service.
What awards or recognition has Robert H. Lurie Comprehensive Cancer Center at Northwestern University received?
The Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago, Illinois, is an NCI-designated Comprehensive Cancer Center, ranking it in the top 1% of cancer centers nationwide. It boasts significant research funding and recognition, highlighted by nine investigators named to the 2023 list of Highly Cited Researchers by Clarivate Analytics, showcasing their broad influence in their respective fields.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.